, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting

163.17 42.9% 202.75 46.0% 39.58 24.3% SG&A 58.51 15.4% 83.78 19.0% 25.27 43.2% EBIT 104.66 27.5% 118.97 27.0% 14.31 13.7% Share of Gain in Associates - - 0.51 0.1% 0.51 - Interest Expenses 0.48 0.1% 0.35

industry-wide and regular cybersecurity drills are conducted to ensure effective risk management. In addition, the conference featured a panel discussion on the topic, “Perspectives on SEC Strategic

AIM 1 Ref.: EFORL039/2017 November 14, 2017 Subject: Management Discussion and Analysis for the third quarter of 2017 (Q3/2017) and for nine month periods ended September 30, 2017 To President The

คำอธิบายและวิเคราะห์งบการเงินรายไตรมาส สำหรับไตรมาสที่ 3 ปี 2545 Management Discussion and Analysis For the 1st Quarter 2019 ended May 31, 2019 AEON Thana Sinsap (Thailand) Public Company Limited

AIM 1 Ref.: EFORL IR 043/2018 November 14, 2018 Subject: Management Discussion and Analysis for the third quarter of 2018 (Q3/2018) and for nine month periods ended September 30, 2018 To President

MDAE_3Q18 Final2 Management Discussion and Analysis for the 3 rd Quarter 2018 ended November 30, 2018 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the

Microsoft Word - 2019-Q4_MDA_Eng_R2.docx   No. CAZ 004/2020 28 February 2020 Subject: Management Discussion and Analysis for the year ended 31 December 2019 Attention: The President The Stock

Public Company Limited’s subsidiary company (“The Company”), Joint Venture Ureka UU co., ltd. (“UU”), in which the company hold 90% of the share. The company plans to increase the shareholding to 99%. On

, 2019, passed a resolution to sell 666,332,580 newly issued shares, at a par value of Baht 1 per share, to existing shareholders through a rights offering process, at a price of Baht 1.20 per share